Cost-Effectiveness of Statin Therapy for Primary Prevention in a Low-Cost Statin Era

With wide availability of low-cost generics, primary prevention with statins has become less expensive. We projected the cost-effectiveness of expanded statin prescribing strategies using low-cost generics and identified conditions under which aggressive prescribing ceases to be cost-effective. We s...

Full description

Saved in:
Bibliographic Details
Published inCirculation (New York, N.Y.) Vol. 124; no. 2; pp. 146 - 153
Main Authors LAZAR, Lawrence D, PLETCHER, Mark J, COXSON, Pamela G, BIBBINS-DOMINGO, Kirsten, GOLDMAN, Lee
Format Journal Article
LanguageEnglish
Published Hagerstown, MD Lippincott Williams & Wilkins 12.07.2011
Subjects
Online AccessGet full text

Cover

Loading…